53 related articles for article (PubMed ID: 20071984)
1. Hematopoietic stem cell transplantation in Zagreb: the first 40 years.
Labar B
Croat Med J; 2023 Apr; 64(2):123-134. PubMed ID: 37131314
[TBL] [Abstract][Full Text] [Related]
2. Clofarabine and total body irradiation (TBI) as conditioning regimen for allogeneic stem cell transplantation in high-risk acute leukemia patients: a two-center retrospective cohort study.
El Cheikh J; Bidaoui G; Atoui A; Terro K; Sharrouf L; Zahreddine A; Moukalled N; Abou Dalle I; Bazarbachi A; Mohty M; Dulery R
Bone Marrow Transplant; 2023 Jun; 58(6):667-672. PubMed ID: 36914730
[TBL] [Abstract][Full Text] [Related]
3. Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS.
Alatrash G; Kidwell KM; Thall PF; Di Stasi A; Chen J; Zope M; Crain AK; Champlin RE; Popat U; Shpall EJ; Jones RB; Andersson BS
Bone Marrow Transplant; 2019 Aug; 54(8):1245-1253. PubMed ID: 30532055
[TBL] [Abstract][Full Text] [Related]
4. Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease.
Hosoya H; Levine J; Abt P; Henry D; Porter DL; Gill S
Blood Adv; 2018 Mar; 2(5):575-585. PubMed ID: 29535106
[TBL] [Abstract][Full Text] [Related]
5. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.
Majhail NS; Farnia SH; Carpenter PA; Champlin RE; Crawford S; Marks DI; Omel JL; Orchard PJ; Palmer J; Saber W; Savani BN; Veys PA; Bredeson CN; Giralt SA; LeMaistre CF
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1863-1869. PubMed ID: 26256941
[TBL] [Abstract][Full Text] [Related]
6. Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.
Pingali SR; Champlin RE
Bone Marrow Transplant; 2015 Sep; 50(9):1157-67. PubMed ID: 25985053
[TBL] [Abstract][Full Text] [Related]
7. Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignancies.
Ricci MJ; Medin JA; Foley RS
World J Stem Cells; 2014 Sep; 6(4):380-90. PubMed ID: 25258660
[TBL] [Abstract][Full Text] [Related]
8. Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.
El-Jawahri A; Pidala J; Inamoto Y; Chai X; Khera N; Wood WA; Cutler C; Arora M; Carpenter PA; Palmer J; Flowers M; Weisdorf D; Pavletic S; Jaglowski S; Jagasia M; Lee SJ; Chen YB
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1341-8. PubMed ID: 24813171
[TBL] [Abstract][Full Text] [Related]
9. Failure of hypomethylating agent-based therapy in myelodysplastic syndromes.
Kadia TM; Jabbour E; Kantarjian H
Semin Oncol; 2011 Oct; 38(5):682-92. PubMed ID: 21943675
[TBL] [Abstract][Full Text] [Related]
10. Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.
Oran B; Wagner JE; DeFor TE; Weisdorf DJ; Brunstein CG
Biol Blood Marrow Transplant; 2011 Sep; 17(9):1327-34. PubMed ID: 21232621
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
12. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry.
Faber E; Koza V; Vitek A; Mayer J; Sedlacek P; Zak P; Zapletalova J; Benesova K; Krejcova H; Steinerova K; Maresova I; Cetkovsky P;
Neoplasma; 2007; 54(5):443-6. PubMed ID: 17688375
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for myelodysplastic syndrome.
Barrett AJ; Savani BN
Semin Hematol; 2008 Jan; 45(1):49-59. PubMed ID: 18179969
[TBL] [Abstract][Full Text] [Related]
14. Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care?
McClune BL; Weisdorf DJ
Curr Opin Hematol; 2010 Mar; 17(2):133-8. PubMed ID: 20071984
[TBL] [Abstract][Full Text] [Related]
15. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
Valcárcel D; Martino R
Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]